Free E-mail Newsletter

Sample Articles

Subscriber Benefits

Neurotech Reports

Subscriber Services




Neurotechnology, the application of electronics and engineering to the human nervous system, has now reached a level of commercial and scientific maturity that will produce enormous benefits to patients and profits to investors. Hundreds of thousands of people have already been helped by neurostimulation products that restore hearing to deaf people, movement to individuals with paralysis, and relief to those with chronic pain or neurological disorders. Please join us as we monitor the growth of this new industry and track the progress from medical technology to commerial products.

Recent Highlights

Depression Market Poised for New Commercial Activity

There are positive signs from vendors of both implanted and noninvasive therapies.

Read the article, free

Neurotech Reports Announces Recipients of 2017 Gold Electrode Awards

The awards were announced at the 2017 Neurotech Leaders Forum.

Read the article, free

Visual Prosthesis Market Moves in New Directions

Several new commercial firms and research teams in the U.S. and Europe are pursuing new approaches.

Read the article, free

Commentary by James Cavuoto

Neurotech Reports editor James Cavuoto comments on privacy issues that have emerged in the era of neurotechnoogy and brain computer interfaces.

Read the article, free

Recent Conference Reports

2017 North American Neuromodulation Society Meeting

International Stroke Conference

American Academy of Neurology Annual Meeting

International Neuromodulation Society Meeting

Neural Interfaces Conference

AAAS Annual Meeting

Neurotech Leaders Forum

BIO CEO & Investor Conference

Society for Neuroscience Meeting

North American Neuromodulation Society Annual Meeting

J.P. Morgan Healthcare Conference

Click here to subscribe.

Recent Vendor Profiles

Nexeon Medsystems


MicroTransponder Inc.

Ossur hf

NeuroPace Inc.

Bioness Inc.

BrainsGate Ltd.

Medtronic Inc.

Click here to subscribe.